ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Letter To the Editor; Closed Meetings Create Aura of Suspicion

August 12, 1994

Breast Cancer Action Plan Committee Outrages By Plans for $14M In NCI Funds

August 1, 1997

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

February 15, 1985

In Brief: NCI’s John Czajkowski Takes Executive Dean Position At Harvard Medical School

February 21, 2014

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

January 30, 2009

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 24, 1975